Clinical Trial Update: Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH [Phase 1]

View source ↗

Summary

Phase 1 study evaluating an anti-recurrence therapy for hepatocellular carcinoma in patients with microvascular invasion and ASPH overexpression following surgi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: UNKNOWN